Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep701 | Thyroid | ECE2021

Grave’s disease in a patient with thyroid hemiagenesis

Jane Pang Eleanor , Aminath Aifa Aboobakuru1 , Sardar Muhammad Shoaib Khan1 , Larsen Niels

IntroductionWe present the case of a 50-year-old lady who was referred to the endocrine clinic with a clinical and biochemical picture suggestive of severe thyrotoxicosis. CT scan of thorax, abdomen and pelvis (CT TAP) was performed to rule out malignancy, which showed left lobe agenesis.Case50-year-old lady presented to the GP with hyperhidrosis and unintentional weight loss. She also reported symptoms of le...

ea0073yi1 | Young Investigator Awards | ECE2021

Circulating myomiRNAs as biomarkers of Cushing’s syndrome

Pivonello Claudia , Patalano Roberta , Negri Mariarosaria , Montò Tatiana , Amatrudo Feliciana , Paola Nicola Di , Iacono Marina , Simeoli Chiara , Ferrigno Rosario , Solari Domenico , Angelis Cristina De , Auriemma Renata Simona , Cappabianca Paolo , Colao Annamaria , Pivonello Rosario

Cushing’s syndrome (CS) is a rare endocrine disease caused by a chronic exposure to endogenous cortisol or exogenous glucocorticoids (GCs). Among multiple comorbidities, impairment of skeletal muscle mass and strength affects 40–70% of patients with active CS and persist even after long-term disease remission. In pathological conditions, GCs excess sustain muscle atrophy and weakness affecting type II muscle fibers. Muscle-specific microRNAs, defined myomiRs, are in...

ea0073aep415 | General Endocrinology | ECE2021

Cushing’s syndrome: Do Cushing’s patients have similar diagnostic and treatment journeys and outcomes to mine?

McBride Margaret

BackgroundHaving experienced Cushing’s syndrome and disease, this author is now a Doctor of Philosophy student studying these medical conditions with the main aim of finding out if others diagnosed with these illnesses have experienced similar diagnostic and treatment journeys with similar outcomes.MethodAn online 2020 survey was conducted on 86 Cushing’s members of the Pituitary Foundation, (Female...

ea0086p72 | Metabolism, Obesity and Diabetes | SFEBES2022

A novel compound heterozygous variant of Gitelman’s syndrome in a patient with Sjorgren’s syndrome: latent rather than acquired?

Tellier Genevieve , Wood Ffion , Searell Catrin , Head Simeon , Wilton Anthony

Gitelman’s syndrome (GS) is an autosomal recessive renal tubular disorder caused by mutations of the SLC12A3 gene coding for the thiazide-sensitive sodium chloride co-transporter (NCCT). Hypokalaemia, hypomagnesaemia, hypocalciuria and metabolic alkalosis are consequent. Sjorgren’s syndrome (SS) is a connective tissue disorder primarily affecting lacrimal and salivary glands resulting in sicca complex. The coincidental presence of both syndromes is rare. A 28 year ol...

ea0085oc9.2 | Oral Communications 9 | BSPED2022

Audit of management of diabetic ketoacidosis in children at The Noah’s Ark Children’s Hospital for Wales

Ahmed Nagla , Shetty Ambika , Ho Pei

Introduction: Diabetic Ketoacidosis (DKA) is a potentially life threatening complication of type-1 diabetes mellitus (T1DM) in children and young people (CYP). An Integrated Care Pathway (ICP) for management of DKA is based on the current British Society for Paediatric Endocrinology and Diabetes (BSPED) guidelines. The BSPED guideline moved away from cautious fluid replacement toward a liberal approach for resuscitation and maintenance fluids based on current evidence. The ICP...

ea0049ep1057 | Pituitary - Clinical | ECE2017

DHEA-S as a marker of the secondary adrenal insufficiency following craniospinal irradiation

Yudina Alla , Pavlova Maria , Tselovalnikova Tatiana , Mazerkina Nadezhda , Arefyeva Irina , Gheludcova Olga

Abstract: The secondary adrenal insufficiency (SAI) is life-threatening disease. 30–50% of patients have SAI following craniospinal irradiation (CSI). The “gold standard” of SAI diagnosis is the insulin tolerance test but it is demanding for patient and medical staff. The simple and reliable test would allow to use ITT rarely. The aim was to evaluate probability of using DHEA-S in SAI diagnosis. 41 patient after CSI non-pituitary brain tumors survivor and 23 hea...

ea0014oc12.5 | Diabetes | ECE2007

The influence of concomitant diabetes mellitus on mortality in Addison’s disease

Bergthorsdottir Ragnhildur , Leonsson-Zachrisson Maria , Odén Anders , Johannsson Gudmundur

Background: The prevalence of type 1 diabetes mellitus (DM) among patients with primary adrenal insufficiency (Addison’s disease) is 3-4 times higher than the expected prevalence in the population. The mortality rate due to DM is more than 3-fold the mortality rate in the background population. The impact of DM on mortality rate in patients with Addison’s disease is not known.Objectives: To study the frequency of DM and its impact on mortality ...

ea0014p343 | (1) | ECE2007

The incidence of Hashimoto’s thyroiditis in the differentiated thyroid carcinoma

Voliotopoulos Vassilios , Gianakopoulos Vassilios , Valais Ioannis

Purpose: Hashimoto’s thyroiditis is medical disease witch affects more than 5% of the population and represents the most common cause of hypothyroidism. The possibility of an immunological and autoimmune mechanism in the pathogenia of the disease has been suggested.Methods and Materials: In 200 patients, who received iodine 131 therapy after total or near total thyroidectomy for one or more cold nodules,in our department last year (71% with papillar...

ea0073aep844 | Late Breaking | ECE2021

The relative’s viewpoint on acromegaly in remission : A psychosocial dimension of a chronic disease

Fourneaux Rachel , Marie Vermalle , Albarel Frederique , Morange Isabelle , Graillon Thomas , Amodru Vincent , Cuny Thomas , Dufour Henry , Brue Thierry , Castinetti Frederic

Aim of the studyA relative can be an asset in dealing with chronic illnesses such as acromegaly where quality of life is altered even after remission. However, it has been shown that quality of life of caregivers can also be impacted. Our main objective was to explore the consequences of acromegaly in remission in the patient-relative dyad in a matter of quality of life and self-esteem.MethodsIn this French m...

ea0070ep307 | Pituitary and Neuroendocrinology | ECE2020

Curability rate of cushing’s disease 1 year posttreatment

Verdes Andreea , Ghenoiu Sandra , Capatina Cristina , Poiana Catalina

Background: Cushing’s disease is characterized by chronic ACTH hypersecretion, leading to hyperplasia of the adrenal zonae reticularis and fasciculata and, therefore, increased secretion of cortisol, androgens and DOC. Cushing’s disease is the most common form of Cushing’s syndrome, being responsible for approximately 80% of reported cases.Aim: To evaluate the curability rate of Cushing’s disease 1 year postoperatively.<p clas...